Psoriasis treatment in patients with sickle cell disease.

Pulusani, Srinidhi; McMurray, Stacy L; Jensen, Kathryne; Jones, Allison V

Pulusani, Srinidhi; McMurray, Stacy L; Jensen, Kathryne; Jones, Allison V.

Affiliation

Pulusani S; Department of Dermatology, The University of Tennessee Health Science Center, Memphis, USA.
McMurray SL; Department of Dermatology, The University of Tennessee Health Science Center, Memphis, USA.
Jensen K; Regional One Health, Memphis, USA.
Jones AV; Department of Dermatology, The University of Tennessee Health Science Center, Memphis, USA.

Cutis ; 103(2): 93-94, 2019 02.

Article in En | MEDLINE | ID: mdl-30893386

Subject(s)

Adalimumab/therapeutic use; Anemia, Sickle Cell/drug therapy; Psoriasis/drug therapy; Adult; Anemia, Sickle Cell/complications; Anemia, Sickle Cell/pathology; Antirheumatic Agents/therapeutic use; Female; Humans; Psoriasis/complications; Psoriasis/pathology; Tumor Necrosis Factor-alpha/antagonists & inhibitors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Adalimumab / Anemia, Sickle Cell Limits: Adult / Female / Humans Language: En Journal: Cutis Year: 2019 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links